<scp>TAS</scp> 3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancerShohei Yoshida, Kazuhisa Minamiguchi|Molecular Oncology|2024Cited by 8